IAM Patent 1000 Ranks 10 Wolf Greenfield Attorneys, More Than Any Other Firm in Boston

“For nearly a century, Boston entrepreneurs and research institutes have been making a beeline to Wolf, Greenfield & Sacks. With over 90% of its practitioners holding science or engineering degrees – and more than two-thirds having an MS, MD or PhD – there is no shortage of technical knowledge in the ranks. As a reflection of this, it has more ranked individuals than any other firm in the Boston section of the IAM Patent 1000 for 2018. Jason Honeyman is a real renaissance man, featuring on the prosecution, transactions and litigation tables. He handles a panoply of portfolio management issues for Vestas Wind Systems, the largest wind turbine company in the world. Equally multi-talented, Edward Russavage and Edward Gates file with finesse and know how to get signatures on the bottom line of lucrative contracts. “The amazing thing about Russavage is that he strives to deeply understand clients’ businesses and makes sure to meet their goals. Of course, he prosecutes patents, but his service goes way further than that; he’s a genuine strategic partner.” Chairman of the firm, Gates brings over 30 years of experience to the table; the pharmaceutical, biotech and medical devices spaces never cease to excite him. Having served as corporate counsel at Amgen, Jeffrey Hsi has a great feel for what the C-suite wants from a report; legalese is of one of his bugbears. Neil Ferraro, Patrick Waller, Timothy Oyer and Jenny Chen are all blindingly efficient prosecutors. Ferraro is a mechanical engineering mage, while Waller and Oyer reign supreme in biochemistry; together they manage Oxford Nanopore’s sensational portfolio. Life sciences briefs are meat and drink for the technically sublime Chen. Michael Albert and Michael Rader lead the litigation strike force. Albert has been supporting Kantar Media in an ongoing battle against TiVo that has been raging for more than five years. Meanwhile, Rader was involved on behalf of Sony in the first successful use of the International Trade Commission’s 100-day programme to invalidate a patent and also got the first ever grant of attorneys’ fees for RPX in the Patent Trial and Appeal Board.”